Analyst Downgrades – NASDAQ:ESPR – Esperion Therapeutics (NASDAQ:ESPR) Stock Gets Downgraded By JPMorgan Chase from Neutral to Underweight

ME Staff
-
0

Analyst Ratings For NASDAQ:ESPR – Esperion Therapeutics (NASDAQ:ESPR)

Today, NASDAQ:ESPR – Esperion Therapeutics (NASDAQ:ESPR) stock was downgraded by JPMorgan Chase from Neutral to Underweight with a price target of $41.00.

Some recent analyst ratings include

  • 5/3/2018-JPMorgan Chase was Downgraded by analysts at JPMorgan Chase from a “Neutral ” rating to a ” Underweight” rating. They now have a $41.00 price target on the stock, up previously from $100.54 .
  • 5/3/2018-Deutsche Bank Reiterated Rating of Buy.
  • 5/2/2018-Bank of America Reiterated Rating of Buy .

Recent Insider Trading Activity For NASDAQ:ESPR – Esperion Therapeutics (NASDAQ:ESPR)
NASDAQ:ESPR – Esperion Therapeutics (NASDAQ:ESPR) has insider ownership of 32.50% and institutional ownership of 90.96%.

  • On 3/29/2018 Roger S Newton, Director, sold 25,000 with an average share price of $72.37 per share and the total transaction amounting to $1,809,250.00.
  • On 1/25/2018 Nicole Vitullo, Director, sold 11,674 with an average share price of $71.79 per share and the total transaction amounting to $838,076.46.
  • On 12/6/2017 Nicole Vitullo, Director, sold 9,326 with an average share price of $53.85 per share and the total transaction amounting to $502,205.10.
  • On 3/22/2017 Dov A Md Goldstein, Director, sold 800,000 with an average share price of $41.66 per share and the total transaction amounting to $33,328,000.00.
  • On 3/21/2017 Gilbert S Omenn, Director, bought 1,000 with an average share price of $42.26 per share and the total transaction amounting to $42,260.00.
  • On 11/1/2016 Narendra D Lalwani, COO, bought 5,000 with an average share price of $9.93 per share and the total transaction amounting to $49,650.00.
  • On 7/6/2016 Mark E Mcgovern, Director, bought 5,000 with an average share price of $10.00 per share and the total transaction amounting to $50,000.00.

Recent Trading Activity for NASDAQ:ESPR – Esperion Therapeutics (NASDAQ:ESPR)
Shares of NASDAQ:ESPR – Esperion Therapeutics closed the previous trading session at 39.83 down -5.92 12.94% with 44.599998474121094 shares trading hands.